Orlandotrader
Nov 8, 5:11 PM
$BCTX 8 Million Shares with fully Diluted at 15 Million Shares. Positive phase 3 Brings 150-300 Million MC per Gemini.
Definitely gonna be a Binary Event due to the Paultry MC of 60 Million fully diluted.
Let’s remember how we got here:
Massively underfunded Bio which had to do many small equity raises that was destroyed by Short Sellers causing Many Reverse Splits and Shareholders Equity Destruction. They were finally able to Engineer a 30 Million Dollar Equity raise several months ago.
Hopefully this will be the Exception.
Feuerstein-Ratain (F-R) Rule, which predicts the Phase 3 clinical trial outcomes of small-cap biotech companies. It was formulated by veteran biotech journalist Adam Feuerstein and Dr. Mark Ratain, an oncologist at the University of Chicago.
The Core Rule
If a public biotechnology company has a market capitalization of
$300 million or less exactly four months before a Phase 3 oncology trial readout, the trial will fail.
2 replies
